Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+
July 22, 2025 02:00 ET Â | Source: Scancell Holdings Plc SCOPE trial…
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ --Â A recently published five-year pharmacovigilance study confirms…
QS Best Student Cities Ranking 2026
London slips, Seoul crowned #1, Asia rises LONDON, July 15, 2025 /PRNewswire/…
Microban International Unveils H2O Shield, a Portfolio of PFAS-Free Water-Resistant Textile Technologies
Tailored solutions provide excellent water repellency while addressing key concerns such as…